By Sneha S K and Amina Niasse Feb 23 (Reuters) - Online telehealth company Hims & Hers Health, which sells weight-loss drugs, ...

Feb 23 (Reuters) - Online telehealth company Hims & Hers Health forecast 2026 revenue above estimates on Monday, betting on ...

Hims & Hers Health (NYSE:HIMS) executives used the company’s fourth-quarter and full-year 2025 earnings call to emphasize ...

Hims & Hers is facing battles on multiple fronts as it seeks to maintain its lucrative business in copycat weight loss drugs.

By Christy Santhosh Feb 19 (Reuters) - Hims & Hers Health said on Thursday it will acquire Australian digital health company ...

The wellness platform’s results arrived amid heightened legal and regulatory scrutiny over its weight-loss-drug business.

Before I hand it over to Andrew, I need to remind you of legal safe harbor and cautionary declarations. The dynamics we have seen over the last eighteen months, including U.S. prices for injectable ...

A whopping 85% of men experience significantly thinning hair by age 50, and two-thirds experience noticeable hair loss by age 35. So, while Hims provides access to a number of different prescription ...

Hims & Hers Health, Inc. ( HIMS) Q4 2025 Earnings Call February 23, 2026 5:00 PM EST ...

Q4 2025 earnings call recap: revenue, EBITDA, subscriber growth, new specialties, and international expansion outlook.

In earnings call, Hims & Hers CEO Andrew Dudum addressed the increased scrutiny on compounded GLP-1s and its impact on the ...

Hims & Hers Health Inc HIMS reported financial results for the fourth quarter after the market close on Monday. Here’s a look at the key details from the print. Hims & Hers Health stock is showing ...